Efficacy and safety of MuShengshu in the treatment of mild-to-moderate atopic dermatitis: protocol for a randomized, double-blind, placebo-controlled trial - Scorecard - MDSpire
Advertisement
Efficacy and safety of MuShengshu in the treatment of mild-to-moderate atopic dermatitis: protocol for a randomized, double-blind, placebo-controlled trial
Clinical Scorecard: Assessment of the Safety and Effectiveness of MuShengshu for Mild to Moderate Atopic Dermatitis: A Protocol for a Randomized, Double-Blind, Placebo-Controlled Study
At a Glance
Category
Detail
Condition
Key Mechanisms
MuShengshu is a weakly acidic bath solution containing traditional Chinese medicine ingredients that may alleviate pruritus and promote skin healing.
Target Population
Care Setting
Key Highlights
Foundational therapies include desonide and triamcinolone acetonide creams, applied concurrently with MuShengshu.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Assess EASI, VAS, IGA, and DLQI at baseline, weeks 1, 2, 4, and 16, with specific criteria for each assessment.
Risks
Patient & Prescribing Data
MSS combined with foundational therapies may enhance treatment efficacy and reduce recurrence; consider potential side effects.
Clinical Best Practices
Incorporate appropriate bathing practices to facilitate skin repair, supported by evidence-based references.
Monitor skin barrier function and pH balance in treatment plans.
Utilize a combination of topical therapies for comprehensive management.
